Jann S, Beretta S, Moggio M, Adobbati L, Pellegrini G
Institute of Neurology, University of Milan, Policlinico Hospital, Italy.
J Neurol Neurosurg Psychiatry. 1992 Jan;55(1):60-2. doi: 10.1136/jnnp.55.1.60.
Two patients were treated with treatment-resistant polymyositis with intravenous immunoglobulin over four days at a dose of 0.4 g/kg/day. Clinical recovery followed within two months. Serum creatine kinase (CK) activity decreased to normal, and a clear improvement in muscle strength was observed. One patient showed neither clinical relapses nor increase in serum CK activity after 20 months. The other showed a mild increase in serum CK activity after 24 months and was successfully retreated with intravenous immunoglobulin. There were no significant adverse side effects.
两名患有难治性多发性肌炎的患者接受了静脉注射免疫球蛋白治疗,为期四天,剂量为0.4 g/kg/天。两个月内临床症状恢复。血清肌酸激酶(CK)活性降至正常,肌肉力量有明显改善。一名患者在20个月后既无临床复发,血清CK活性也未升高。另一名患者在24个月后血清CK活性轻度升高,再次静脉注射免疫球蛋白治疗成功。未出现明显的不良副作用。